Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
The Open Virology Journal|May 7, 2014
Both Cyclophilin Inhibitors and Direct-Acting Antivirals Prevent PKR Activation in HCV-Infected CellsMichael Bobardt, Udayan Chatterji, Precious Lim, et al.Plos One|July 22, 2016
Cyclophilin Inhibitors Remodel the Endoplasmic Reticulum of HCV-Infected Cells in a Unique Pattern Rendering Cells Impervious to a ReinfectionUdayan Chatterji, Michael Bobardt, Lana Schaffer, et al.Viruses|October 28, 2023
The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral ActivityWinston Stauffer, Michael Bobardt, Daren Ure, et al.Biorxiv : the Preprint Server for Biology|August 30, 2023
The Cyclophilin Inhibitor Rencofilstat Decreases HCV-induced Hepatocellular Carcinoma Independently of Its Antiviral ActivityWinston Stauffer, Michael Bobardt, Daren Ure, et al.Antimicrobial Agents and Chemotherapy|February 11, 2015
Cyclophilin and NS5A inhibitors, but not other anti-hepatitis C virus (HCV) agents, preclude HCV-mediated formation of double-membrane-vesicle viral factoriesUdayan Chatterji, Michael Bobardt, Andrew Tai, et al.Plos One|January 25, 2020
The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized miceMichael Bobardt, Joseph Kuo, Udayan Chatterji, et al.Plos One|April 4, 2024
Cyclophilin D knockout significantly prevents HCC development in a streptozotocin-induced mouse model of diabetes-linked NASHWinston T Stauffer, Michael Bobardt, Daren R Ure, et al.Plos One|August 9, 2020
Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver miceMichael Bobardt, Magnus Joakim Hansson, Patrick Mayo, et al.Plos One|May 20, 2021
The combination of the NS5A and cyclophilin inhibitors results in an additive anti-HCV inhibition in humanized mice without development of resistanceMichael Bobardt, Christina M Ramirez, Marc M Baum, et al.Plos One|June 11, 2019
The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic micePhilippe Gallay, Daren Ure, Michael Bobardt, et al.Pageof 4